Capital Counsel LLC Edwards Lifesciences Corp Transaction History

Capital Counsel LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$69.28 - $93.38 $76,208 - $102,718	-1,100 Reduced 18.8%	4,750 $329,000
Q2 2023 Aug 14, 2023	BUY	$81.41 - $94.33 $89,551 - $103,763	1,100 Added 23.16%	5,850 $551,000
Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $51,982 - $59,157	-700 Reduced 12.84%	4,750 $392,000
Q4 2022 Feb 09, 2023	SELL	$68.3 - $87.44 $56.4 Million - $72.2 Million	-825,854 Reduced 99.34%	5,450 $406,000
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $2.44 Million - $3.17 Million	29,564 Added 3.69%	831,304 $68.7 Million
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $22.7 Million - $33.6 Million	-262,179 Reduced 24.64%	801,740 $76.2 Million
Q1 2022 May 16, 2022	BUY	$101.96 - $128.34 $23.2 Million - $29.2 Million	227,722 Added 27.23%	1,063,919 $125 Million
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $51 Million - $62.7 Million	479,749 Added 134.59%	836,197 $108 Million
Q3 2021 Nov 12, 2021	BUY	$102.91 - $122.75 $36.7 Million - $43.8 Million	356,448 New	356,448 $40.4 Million

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Capital Counsel LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Counsel LLC with notifications on news.